Researchers assessed the prevalence of symptoms of anxiety and depression in adult patients with irritable bowel disease.
Researchers summarized the current knowledge on treatment options for extraintestinal manifestations in patients with IBD, while calling attention to gaps in the research.
Initiation of opioid use during a flare of symptoms can eventually lead to chronic opioid use (COU), which can have detrimental effects on a patient’s IBD, as well as their overall clinical health.
Researchers investigated whether psychological comorbidities predated the diagnosis and propagation of inflammatory bowel disease.
Researchers examined the effects of nutritional therapy on bone health in pediatric patients with Crohn Disease.
Investigators sought to determine the safety and feasibility of conventional and non-conventional laparoscopic strictureplasties for the treatment of Crohn Disease.
Reviewers provided an overview of evidence for appropriate diagnostic pathway and management of Crohn disease following GI cancer onset.
A team of investigators sought to determine how concomitant proton pump inhibitor treatment influences response to infliximab therapy in patients with inflammatory bowel disease.
A team of investigators evaluated the prevalence of and sought to identify risk factors associated with low health literacy in a diverse population of individuals with inflammatory bowel disease.
Investigators performed a literature review of current strategies for monitoring kidney function in patients undergoing treatment with 5-ASA for inflammatory bowel disease.
For veterans with inflammatory bowel disease, the risk for severe pneumococcal disease is increased with Crohn disease and with more comorbidities, and pneumococcal vaccination is associated with a reduced risk for SPD.
A team of investigators examined the association between disease activity in individuals with inflammatory bowel disease and the development of symptoms of depression and anxiety.
More research and follow-up on infliximab is needed to determine the appropriate length of treatment and who will benefit most from treatment.
A team of investigators conducted a nationally representative, population-based cohort study to assess the use of antidepressant medication in patients having undergone surgery for Crohn disease.
Although the definition of remission varies, the goal of IBD treatment is to achieve and sustain remission.
A team of investigators sought to determine the influence of infliximab on gut bacterial and fungal composition in patients with inflammatory bowel disease.
As Crohn disease perianal fistulas often do not respond to available treatments, researchers developed a patient-derived quality-of-life tool to evaluate the impact of the condition on patients.
Risankizumab is currently FDA-approved under the brand name Skyrizi for the treatment of moderate to severe plaque psoriasis.
Interview study identified categories in which improved psychological support services are needed for these patients.
Lower socioeconomic status is associated with worse outcomes for inflammatory bowel disease.